CluenexManhattan Associates MANH
Manhattan Associates scores good on business quality (7.1 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Manhattan Associates does
Manhattan Associates sells supply chain and inventory software to enterprises managing complex distribution networks. Clients pay subscription and maintenance fees to keep warehouses running efficiently.
- What it does best
It dominates supply chain execution software through deep enterprise integration, delivering a gross margin of 55.9% compared to FICO's 85.1%. This stickiness makes warehouse software nearly impossible to rip out once installed.
- The main risk
Valuation risk looms large as the stock trades at $204.15 against an intrinsic value of $113.37, leaving zero margin for error if software deployment timelines slip.
Quality, check by check
Scored against its own industry, from company filings.
Operating margins hit 25.7% while FCF margin sits in the 86th sector percentile, driven by high-margin software delivery that scales exceptionally well.
Its moat relies on mission-critical switching costs that lock in enterprise logistics teams, backed by an operating margin ranking in the 74th sector percentile.
Revenue grew to $1.1B, expanding at 3.7% annually, which marks a notable cooling phase compared to its multi-year historical acceleration.
Zero debt and $329 million in cash back up a fortress balance sheet, alongside $399 million in free cash flow, getting stronger by the quarter.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
3 sold $1.9M outside pre-planned sales.
Our sealed record on MANH
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Manhattan Associates scores good on the Cluenex quality check (7.1 of 10), measured against its own industry. Profitability is strong, moat fair, growth slow and financial health strong.
In the last 90 days of SEC Form 4 filings: 3 sold $1.9M outside pre-planned sales.
Oct 27, 2026.
See MANH today
- Today's verdict on MANH, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Manhattan Associates (MANH)”, https://cluenex.com/stocks/manh/, data as of Oct 10, 2026.